Bone morphogenetic proteins and spinal surgery

Spine

Volumn 28, Issue 15 SUPPL., 2003, Pages

  Sandhu, Harvinder S ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Clinical trials; Recombinant bone morphogenetic proteins; rhBMP 2; rhBMP 7; Spinal fusion

Indexed keywords

OSTEOGENIC PROTEIN 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

AUTOGRAFT; BONE GRAFT; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; INTERVERTEBRAL DISK DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SPINE DISEASE; SPINE FUSION; SPINE SURGERY;

EID: 0042567582     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200308011-00012     Document Type: Review

References (35)

1. Urist MR. Bone. Formation by autoinduction. Science 1965;150:893-9.
2. Urist MR, Mikulski A, Lietze A. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979;76:1828-32.
3. Urist MR, Silverman BF, Buring K, Dubuc FL, Rosenberg JM. The bone induction principle. Clin Orthop 1967;53:243-83.
4. Johnson EE, Urist MR, Finerman GA. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop 1988;230:257-65.
5. Johnson EE, Urist MR, Finerman GA. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin Orthop 1988;236:249-57.
6. Sandhu HS, Kanim LEA, Dawson ED, et al. The safety and efficacy of purified native human bone morphogenetic protein for spinal fusion. A ten-year followup study. Presented at the 64th Annual Meeting of the American Academy of Orthopaedic Surgeons, Orlando, FL, 1997.
7. Edwards JT, Diegmann MH, Scarborough NL. Osteoinduction of human demineralized bone: Characterization in a rat model. Clin Orthop 1998;357:219-28.
8. Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988;85:9484-8.
9. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-34.
10. Celeste AJ, lannazzi JA, Taylor RC, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;77:9943-7.
11. Uludag H, Gao T, Porter TJ, Friess W, Wozney JM. Delivery systems for BMPs: Factors contributing to protein retention at an application site. J Bone Joint Surg [Am] 2001;83-A(Suppl 1, Pt 2):S128-35.
12. Sandhu HS, Kanim LE, Kabo JM, et al. Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 1995;20:2669-82.
13. Gazdag AR, Lane JM, Glaser D, Forster RA. Alternatives to autogenous bone graft: Efficacy and indications. J Am Acad Orthop Surg 1995;3:1-8.
14. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
15. Sandhu HS, Kanim LEA, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-22.
16. Sandhu HS, Kanim LEA, Toth JM, et al. Experimental spinal fusion with recombinant bone morphogenetic protein-2 without decortication of osseous elements. Spine 1997;22:1171-80.
17. Cook SD, Dalton JE, Tan EH, Whitecloud TS III, Rueger DC. In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 1994;19:1655-63.
18. Cunningham BW, Shimamoto N, Sefter J, et al. Osseointegration of autograft vs osteogenic protein-1. NASS 2001;43.
19. Sandhu HS, Kabo JM, Turner AS, Lui D, Kanim LEA, Toth JM. rhBMP-2 augmentation of titanium fusion cages for experimental anterior lumbar fusion. NASS 1996;47.
20. Zdeblick TA, Ghanayem AJ, Rapoff AJ et al. Cervical interbody fusion cage: An animal model with and without bone morphogenetic protein. Spine 1998;23:758-66.
21. Chirossel PEEK reference
22. Martin GJ, Boden SD, Morone MA, Moskovitz PA. Posterolateral intertransverse process spinal arthrodesis with rbBMP-2 in a non-human primate: Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 1999;12(3):179-86.
23. Fischgrund JS, James SB, Chabot MC, et al. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 1997;10(6):467-72.
24. Boden S, Martin G, Horton WC, Truss T, Sandbu H. Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody tbreaded cage. J Spinal Disord 1998;11(2):95-101.
25. Boden S, Martin G, Morone MA, Ugbo J, Moskovitz P. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein-2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 1999;24:1179-85.
26. Akamaru T, Suh D, Boden SD, et al. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion. Spine 2003;28:429-34.
27. McKay B, Sandhu HS. Use of recombinant human bone morphogenetic protein-2 in spinal fusion applications. Spine 2002;27(16 Suppl 1):S66-85.
28. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine 2000;25:376-81.
29. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15(5):337-49.
30. Zdeblick TA, Heim SE, Kleeman TJ, et al. Laparoscopic approach with tapered metal cages: rhBMP-2 vs. autograft. NASS 2001;200.
31. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-408.
32. Alexander JT, Branch CL Jr, Haid RW Jr, et al. An analysis of the use of rhBMP-2 in PLIF constructs: Clinical and radiographic outcomes. Presented at the 18th Annual Meeting of the American Association of Neurological Surgeons and Congress of Neurological Surgeons Section on Disorders of the Spine and Peripheral Nerves, Orlando, FL, February 27 to March 2, 2002.
33. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662-73.
34. Patel TS, Vaccaro AR, Truumees E, et al. A safety and efficacy of osteogenic protein-1 (OP-1) as an adjunct to posterolateral lumbar fusion. NASS 2001.
35. Johnsson R, Stromqvist B, Aspenberg P. Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies. Spine 2002;27:2654-61.